Courtet Philippe, Olié Émilie
Bull Acad Natl Med. 2014 Apr-May;198(4-5):881-92.
Suicide is a major public health problem worldwide, with about 1.5 million deaths each year France ranks 7th in the EU Patients with depression account for the majority of completed suicides. As most of these individuals are not adequately treated, it is conceivable that better treatment of depression would reduce suicide mortality. However, the last ten years have seen a controversy over a possible suicidogenic effect of antidepressants. Here we summarize data from the different types of studies that have cast a shadow over these drugs which can save lives when used effectively to treat depression. Better knowledge of the pathophysiology of "suicidal behaviour disorder" should identify therapeutic targets for innovative agents capable of preventing suicide.
自杀是一个全球性的重大公共卫生问题,每年约有150万人死亡。法国在欧盟中排名第七,抑郁症患者占自杀死亡者的大多数。由于这些人中大多数未得到充分治疗,可以想象,更好地治疗抑郁症将降低自杀死亡率。然而,在过去十年中,关于抗抑郁药可能产生的自杀诱发效应存在争议。在此,我们总结了不同类型研究的数据,这些研究给这些药物蒙上了阴影,而这些药物在有效用于治疗抑郁症时可以挽救生命。更好地了解“自杀行为障碍”的病理生理学,应该能够确定能够预防自杀的创新药物的治疗靶点。